Dueling Messages For Pharma From US Medicaid Formulary Plan

 
• By Michael McCaughan

The innovator biopharma industry understandably concerned about a Trump Administration proposal to allow states to implement restrictive formularies while still collecting mandatory rebates. But the formulary protections in the Trump plan are an important message about the likely shape of any future changes to the US market.

two couple are showing half full and half empty side of water glass with their fingers
How should drug sponsors look at the formulary provisions of the Medicaid block grants proposal? • Source: Shutterstock

More from Medicaid

More from Government Payers